Biotec Pharmacon ASA (NO) – Phase III Results With SBG for Diabetic Foot Ulcer Not Positive
Posted by: DrugsNews on: 23 Nov, 2009
- In: Drugs News| News
- Comment!
Biotec Pharmacon ASA (NO) – Phase III Results With SBG for Diabetic Foot Ulcer Not Positive
(Oslo/Tromsø, 23 November 2009) Biotec
Pharmacon has received the results from both its
phase III studies with SBG for diabetic foot ulcer and regrets to
inform that the results are not positive. The studies failed to
show superiority of SBG…
Read more about Biotec Pharmacon ASA (NO) – Phase III Results With SBG for Diabetic Foot Ulcer Not Positive
| Indian Pharmacy! Looking for Generic Medications? Quality Drugs at affordable prices! Reliable Indian Pharmacy www.IndianPharmacy.org |
#1 Canadian Pharmacy Online! The Lowest Prices from Canadian Drugstore! Various payments, secure shopping, worldwide shipping! www.CanadianPharmacyLtd.org |
What are the Drugs-Review websites?
The Drugs-Review websites are NOT but will be your number one stop for all the latest news, comment and pharmaceutical industry information.
Related posts:
- Lower-Extremity Amputation Risk Following Charcot Arthropathy and Diabetic Foot Ulcer
- Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program
- EVALUATION OF DIABETIC FOOT ULCER HEALING WITH HYPERSPECTRAL IMAGING OF OXYHEMOGLOBIN AND DEOXYHEMOGLOBIN
